SCHEMBL302276

SCHEMBL302276

NC(=O)N1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1363715 1.00
SCHEMBL8364865 0.97 ALDH1A1 (0.55)
SCHEMBL4129583 0.97 ALDH1A1 (0.55)
SCHEMBL5457 0.97
SCHEMBL14511334 0.97 ALDH1A1 (0.55)
SCHEMBL23963672 0.97 ALDH1A1 (0.55)
SCHEMBL2281541 0.97
SCHEMBL7749269 0.97 ALDH1A1 (0.55)
Hydrochloric Acid SCHEMBL9355473 0.97 ALDH1A1 (0.48)
SCHEMBL1363949 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2782 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118087308-B Double-color erasable thermosensitive paper and preparation method thereof HUNAN DINGYI ZHIYUAN TECHNOLOGY DEVELOPMENT Co.,Ltd. (CN) 2026-05-26 CN claimed
EP-3983081-B1 AMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS LLC (US) 2026-03-11 EP claimed
EP-3623372-B1 PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS VALO HEALTH INC (US) 2026-02-04 EP claimed
US-20250333440-A1 Azole Tripeptides as Vasodilators UNIV KANSAS (US) 2025-10-30 US claimed
EP-4598927-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Tenvie Therapeutics Inc. (US) 2025-08-13 EP claimed
EP-4188924-B1 ANTAGONIST COMPOUNDS ADORX THERAPEUTICS LTD (GB) 2025-06-18 EP claimed
EP-4499828-A1 DYSTROPHIN EXON SKIPPING OLIGONUCLEOTIDES BioMarin Pharmaceutical Inc. (US) 2025-02-05 EP claimed
EP-4486722-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Nico Therapeutics, Inc. (US) 2025-01-08 EP claimed
WO-2024233303-A1 DYSTROPHIN EXON SKIPPING OLIGONUCLEOTIDES BIOMARIN PHARMACEUTICAL INC. (US) 2024-11-14 WO claimed
US-20240368596-A1 DYSTROPHIN EXON SKIPPING OLIGONUCLEOTIDES BIOMARIN PHARMACEUTICAL INC. 2024-11-07 US claimed
US-4810721-A ANTIAMNESIA SUNTORY LIMITED (JP) 1989-03-07 US claimed
EP-0268281-A2 Pyrrolidineamide derivative having anti-prolyl endopeptidase activity, compositions comprising the same, processes for the preparation of the same, and the use of the same for the preparation of a medicament of therapeutic value SUNTORY LIMITED (JP) 1988-05-25 EP claimed
EP-0232849-A2 Pyrrolidineamide derivative of acylamino acid, pharmaceutical composition and use SUNTORY LIMITED (JP) 1987-08-19 EP claimed
US-4661512-A Adamantanamine derivatives, processes for their preparation and drugs in which they are present S. A. PANMEDICA (FR) 1987-04-28 US claimed
EP-0167449-A2 New ganglioside derivatives FIDIA S.p.A. (IT) 1986-01-08 EP claimed
EP-0030140-A2 Processes for preparing herbicidal N-(substituted heterocyclicaminocarbonyl)-aromatic sulfonamides E.I. DU PONT DE NEMOURS AND COMPANY (US) 1981-06-10 EP claimed
US-4166903-A 5-Hydroxy-PGI1 pyrrolidylamides THE UPJOHN COMPANY (US) 1979-09-04 US claimed
US-4137403-A 9-Deoxy-9-methylene-PGF2 cycloamides THE UPJOHN COMPANY (US) 1979-01-30 US claimed
US-4129727-A 9-Deoxy-9-methylene-PGF1 -pyrrolidylamides THE UPJOHN COMPANY (US) 1978-12-12 US claimed
US-4016257-A Amide derivatives of acids, an antibiotic produced by Polyangium cellulosum var. fulvum WARNER-LAMBERT COMPANY (US) 1977-04-05 US claimed